AstraZeneca slumps on report CEO is heading to Teva – New York Daily News
Exclusive: Teva poised to raise its stake in Mylan - sources
Teva to pay $523m. to New York as it looks to move past opioid lawsuits - The Jerusalem Post
Rhode Island takes Teva to trial in multibillion-dollar opioid case | Business Insurance
Exclusive: CVS to Cover Migraine Drugs From Teva, Lilly; Excludes Amgen
What's 'down' with Teva? - Israel News - The Jerusalem Post
U.S. states sue Mylan, Teva, others for fixing drug prices - Mitchell Republic | News, weather, sports from Mitchell South Dakota
Teva Pharmaceutical Is in Recovery - WSJ
Teva to pay $85m to Oklahoma over opioid case
Teva Pharm to lay off a quarter of workforce, suspends dividend | Reuters
Teva hopes Sanofi collaboration will lead to blockbuster IBD drug | SaltWire
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Teva's $420mn investor settlement to be mostly covered by insurers | The Insurer
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva settles shareholder lawsuit over generic drug | Business Insurance
Teva CEO exits amid crisis of confidence at drugmaker | Fox Business
Why Europe's Drug Shortages May Get Worse
Teva Pharm sees lower 2024 profit after large Q4 beat | Nasdaq
Teva expects to start paying U.S. opioid settlement in 2023: CEO | Business Insurance
Teva and Eli Lilly scrap over migraine drug rights — MedWatch
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Drugmaker Teva looks to sell Medis business to help cut debt | Reuters
Teva Pharmaceutical Industries isn't out of the woods yet -February 01, 2024 at 04:41 am EST | MarketScreener
